In 2013, chromosomal deletions and sequence alterations of the chromatin-remodeling genes ARID1A and ARID1B were reported in 11% of neuroblastoma cases and were shown to be associated with decreased survival [57]. The gene discussed is ARID1A; the disease is neuroblastoma.